News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Graham G. Walmsley
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
4
| Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Bought 25,000 shares
@ $42.059, valued at
$1.1M
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2023 |
4/A
| Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Bought 400,000 shares
@ $26, valued at
$10.4M
Bought 120,000 shares
@ $42, valued at
$5M
|
|
| 05/23/2023 |
4
| Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Bought 400,000 shares
@ $26, valued at
$10.4M
Bought 120,000 shares
@ $42, valued at
$5M
|
|
| 06/27/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| Graham G. Walmsley (Director) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC|
Txns:
| Bought 20,000 shares
@ $76, valued at
$1.5M
|
|
| 11/23/2020 |
4
| Graham G. Walmsley (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Converted 1,400,761 shares
@ $0
Converted 1,183,114 shares
@ $0
Bought 1,160,000 shares
@ $19, valued at
$22M
Converted 1,400,761 convertible preferred
@ $0
Converted 1,183,114 convertible preferred
@ $0 |
|
| 11/20/2020 |
3
| Graham G. Walmsley (Director) has filed a Form 3 on Lifesci Acquisition II Corp. |
| 11/20/2020 |
4/A
| Graham G. Walmsley (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Bought 339,578 convertible preferred
@ $4.7117, valued at
$1.6M
|
|
| 11/19/2020 |
4
| Graham G. Walmsley (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Bought 339,578 convertible preferred
@ $4.7117, valued at
$1.6M
Bought 1,183,114 convertible preferred
@ $11.0623, valued at
$13.1M
Granted 21,520 options to buy
@ $19, valued at
$408.9k
|
|
| 11/18/2020 |
3
| Graham G. Walmsley (Director) has filed a Form 3 on Olema Pharmaceuticals, Inc. |
| 07/21/2020 |
4
| Graham G. Walmsley (Director) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC|
Txns:
| Converted 2,105,901 shares
@ $0
Bought 975,000 shares
@ $19, valued at
$18.5M
Converted 2,105,901 convertible preferred
@ $0 |
|
| 07/17/2020 |
4
| Graham G. Walmsley (Director) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC|
Txns:
| Granted 24,009 options to buy
@ $19, valued at
$456.2k
|
|
| 07/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/02/2020 |
4
| Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 13,000 options to buy
@ $25.2, valued at
$327.6k
|
|
| 04/01/2020 |
4
| Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Exercised 2,168 shares
@ $19.97, valued at
$43.3k
Exercised 2,168 options to buy
@ $19.97, valued at
$43.3k
|
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
3
| Graham G. Walmsley (Director) has filed a Form 3 on Akero Therapeutics, Inc. |
|
|